Interestingly, our in vivo results show that although hr-anxA1 treatment did not affect intimal xanthoma and small lesion formation it afforded substantial inhibitory effects on progression of small lesions towards advanced lesions. This evidence concerns the gene ANXA1 and xanthoma.